Skip to main content
. 2018 Aug;108(8):1031–1034. doi: 10.2105/AJPH.2018.304446

TABLE 1—

Substance Use Prevalence Among Lesbian, Gay, Bisexual, and Questioning Adolescents and Heterosexual Adolescents in the United States: National Youth Risk Behavior Survey (YRBS), 2015

Heterosexual Adolescents
LGBQ Adolescents
Substancea Unweighted No. Weighted Prevalence, %b (95% CI) Unweighted No. Weighted Prevalence, %b (95% CI) Adjusted RR (95% CI)
Use in past 30 d
 Any substancec 11 152 42.2 (39.3, 45.2) 1 373 51.2 (47.4, 55.1) 1.27 (1.14, 1.41)
 Alcohol 11 840 32.1 (29.5, 34.6) 1 497 38.9 (35.1, 42.6) 1.21 (1.05, 1.38)
 Cigarettes 12 518 9.8 (8.2, 11.4) 1 615 17.9 (14.6, 21.2) 1.83 (1.34, 2.42)
 Cigars 12 647 9.8 (8.4, 11.1) 1 705 14.1 (11.1, 17.1) 1.50 (1.13, 1.94)
 Cocaine . . . . . . . . . . . . . . .
 Ecstasy . . . . . . . . . . . . . . .
 Electronic vapor usage (“vaping”)d 12 809 23.4 (21.2, 25.6) 1 703 28.5 (25.6, 31.3) 1.22 (1.04, 1.43)
 Hallucinogens . . . . . . . . . . . . . . .
 Heroin . . . . . . . . . . . . . . .
 Inhalants . . . . . . . . . . . . . . .
 Marijuana 12 761 20.7 (18.1, 23.2) 1 665 30.2 (27.1, 33.3) 1.49 (1.24, 1.77)
 Methamphetamine . . . . . . . . . . . . . . .
 Prescription drugse . . . . . . . . . . . . . . .
 Smokeless tobacco 12 620 7.2 (5.9, 8.4) 1 697 6.9 (4.6, 9.2) 0.84 (0.49, 1.35)
 Steroids . . . . . . . . . . . . . . .
 Synthetic marijuana . . . . . . . . . . . . . . .
Use in lifetime
 Any substancec 9 042 71.1 (67.9, 74.3) 1 143 80.1 (76.8, 83.4) 1.12 (1.06, 1.19)
 Alcohol 12 619 62.5 (59.7, 65.3) 1 645 71.6 (67.8, 75.4) 1.15 (1.06, 1.23)
 Cigarettes 11 494 30.5 (27.0, 34.1) 1 503 47.3 (42.5, 52.2) 1.63 (1.37, 1.92)
 Cigars . . . . . . . . . . . . . . .
 Cocaine 12 868 4.2 (3.4, 4.9) 1 724 11.0 (7.6, 14.4) 2.28 (1.43, 3.45)
 Ecstasy 12 848 4.1 (3.5, 4.7) 1 721 10.8 (8.5, 13.1) 2.62 (1.81, 3.64)
 Electronic vapor usage (“vaping”)d 12 632 44.2 (41, 47.4) 1 659 50.7 (47.3, 54.2) 1.19 (1.05, 1.35)
 Hallucinogens 9 506 5.5 (4.5, 6.5) 1 228 12.3 (9.2, 15.3) 2.70 (1.92, 3.65)
 Heroin 12 858 1.3 (0.9, 1.7) 1 731 6.6 (3.9, 9.3) 3.14 (1.69, 5.42)
 Inhalants 12 631 5.6 (4.9, 6.3) 1 692 16.8 (13.4, 20.2) 2.51 (1.89, 3.29)
 Marijuana 12 673 37.5 (34.1, 40.8) 1 650 49.9 (45.6, 54.1) 1.40 (1.22, 1.59)
 Methamphetamine 12 377 2.1 (1.6, 2.6) 1 627 8.6 (5.7, 11.6) 3.58 (2.01, 5.88)
 Prescription drugse 12 840 15.5 (14.2, 16.9) 1 726 26.2 (23.3, 29.2) 1.63 (1.37, 1.90)
 Smokeless tobacco . . . . . . . . . . . . . . .
 Steroids 12 684 2.6 (2.1, 3.1) 1 703 9.1 (5.9, 12.3) 2.68 (1.54, 4.33)
 Synthetic marijuana 12 890 8.6 (7.2, 10.0) 1 735 13.7 (10.6, 16.9) 1.56 (1.04, 2.25)

Note. CI = confidence interval; LGBQ = lesbian, gay, bisexual, or questioning; RR = rate ratio. Asterisks indicate not calculated. The sample size was n = 14 703 (15 624 total 2015 YRBS respondents − 921 respondents who did not report their sexual orientation). Prevalence estimates were drawn from the 2015 National Youth Behavioral Risk Survey after applying survey weights to make the sample nationally representative.

a

All substance use–related outcomes in the 2015 national YRBS were analyzed.

b

Represents an affirmative response for using the relevant substance within 30 d of being surveyed or lifetime.

c

This is a composite for use of any of the listed substances within the given timeframe.

d

Refers to use of an electronic vapor device.

e

Refers to a prescription drug that was not prescribed by a physician.